Article
Prolactin Receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in Acute Myeloid Leukemia
2022-05-31
Abstract excerpt
<h4>Background: </h4> Development of precision medicine requires the identification of easily detectable and druggable biomarkers. Despite recent targeted drug approvals, prognosis of acute myeloid leukemia (AML) patients needs to be greatly improved, as relapse and refractory disease are still difficult to manage. Thus, new therapeutic approaches are needed. Based on in silico -generated preliminary data and the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8352605f-8bb3-576e-abbe-b9608029570a
- DOI
- 10.21203/rs.3.rs-1688278/v1
